Analyst Ratings for Boston Scientific (BSX)
BSX Rating Summary
BSX Price Target Summary
- Highest: $130.00 (Leerink Partners)
- Lowest: $94.00 (Wells Fargo)
- Average: $109.61
* Over Last 12-Mos
Overall Rating:
BUY
Rating Trend:
Avg. $ Target:
$109.61 (+53.6%)
* Over Last 12-Mos
Rating Score: 8.3 / 10
Percentile Rank: 86%
Avg. $ Target:
$109.61 (+53.6%)
* Over Last 12-Mos
Rating Score: 8.3 / 10
Percentile Rank: 86%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 12/8/2025 | Nephron | Chris Pasquale | Downgrade | Hold (Buy) |
105.00 (N/A) |
97.52 (71.35) |
-26.84% | Details |
| 10/3/2025 | Erste Group | Hans Engel | Downgrade | Hold (Buy) |
N/A (N/A) |
96.22 (71.35) |
-25.85% | Details |
 |
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
